Skip to main content
SpringerLink
Log in

Lokale Aktivierung und Inaktivierung der Steroidhormone, insbesondere der Sexualhormone

  • Chapter
Molekularmedizinische Grundlagen von para- und autokrinen Regulationsstörungen

Part of the book series: Molekulare Medizin ((MOLMED))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 29.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

6.1.8 Literatur

  • Andersson S, Berman DM, Jenkins EP, Russell DW (1991) Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism. Nature 354: 159–161

    Article  PubMed  CAS  Google Scholar 

  • Baes M, Huyghe S, Carmeliet P, Declercq PE, Collen D, Mannaerts GP, Van Veldhoven PP (2000) Inactivation of the peroxisomal multifunctional protein-2 in mice impedes the degradation of not only 2-methyl-branched fatty acids and bile acid intermediates but also of very long chain fatty acids. J Biol Chem 275: 16329–16336

    Article  PubMed  CAS  Google Scholar 

  • Behl C (2002) Oestrogen as a neuroprotective hormone. Nat Rev Neurosci 3: 433–442

    PubMed  CAS  Google Scholar 

  • Belanger A, Pelletier G, Labrie F, Barbier O, Chouinard S (2003) Inactivation of androgens by UDP-glucuronosyl-transferase enzymes in humans. Trends Endocrinol Metab 14: 473–479

    Article  PubMed  CAS  Google Scholar 

  • Blomquist CH (1995) Kinetic analysis of enzymic activities: prediction of multiple forms of 17 beta-hydroxysteroid dehydrogenase. J Steroid Biochem Mol Biol 55: 515–524

    Article  PubMed  CAS  Google Scholar 

  • Boehmer AL, Brinkmann AO, Sandkuijl LA et al. (1999) 17Beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations. J Clin Endocrinol Metab 84: 4713–4721

    Article  PubMed  CAS  Google Scholar 

  • Breton R, Housset D, Mazza C, Fontecilla-Camps JC (1996) The structure of a complex of human 17beta-hydroxysteroid dehydrogenase with estradiol and NADP+ identifies two principal targets for the design of inhibitors. Structure 4: 905–915

    Article  PubMed  CAS  Google Scholar 

  • Bulun SE, Gurates B, Fang Z et al. (2002) Mechanisms of excessive estrogen formation in endometriosis. J Reprod Immunol 55: 21–33

    Article  PubMed  CAS  Google Scholar 

  • Carsol JL, Adamski J, Guirou O, Gerard H, Martin PM, Launoit Y de (1996) 17 beta-Hydroxysteroid dehydrogenase activity correlates with the type-2 17 beta-hydroxysteroid dehydrogenase mRNA abundance in human meningioma tumors. Neuroendocrinology 64: 70–78

    PubMed  CAS  Google Scholar 

  • Carson-Jurica MA, Schrader WT, O’Malley BW (1990) Steroid receptor family: structure and functions. Endocr Rev 11: 201–220

    PubMed  CAS  Google Scholar 

  • Castagnetta LA, Carruba G, Traina A et al. (1997) Expression of different 17beta-hydroxysteroid dehydrogenase types and their activities in human prostate cancer cells. Endocrinology 138: 4876–4882

    Article  PubMed  CAS  Google Scholar 

  • Castano Suarez E, Segurado Rodriguez A, Guerra Tapia A, Simon de las Heras R, Lopez-Rios F, Coll Rosell MJ (1997) Ichthyosis: the skin manifestation of multiple sulfatase deficiency. Pediatr Dermatol 14: 369–372

    PubMed  CAS  Google Scholar 

  • Chen G, Zhang D, Jing N, Yin S, Falany CN, Radominska-Pandya A (2003) Human gastrointestinal sulfotransferases: identification and distribution. Toxicol Appl Pharmacol 187: 186–197

    Article  PubMed  CAS  Google Scholar 

  • Chen W, Song MS, Napoli JL (2002) SDR-O: an orphan short-chain dehydrogenase/reductase localized at mouse chromosome 10/human chromosome 12. Gene 294: 141–146

    Article  PubMed  CAS  Google Scholar 

  • Clark JH, Schrader WT, O’Malley BW (1992) Mechanisms of action of steroid hormones. Saunders, Philadelphia

    Google Scholar 

  • Couture JF, Legrand P, Cantin L, Luu-The V, Labrie F, Breton R (2003) Human 20alpha-hydroxysteroid dehydrogenase: crystallographic and site-directed mutagenesis studies lead to the identification of an alternative binding site for C21-steroids. J Mol Biol 331: 593–604

    Article  PubMed  CAS  Google Scholar 

  • Cross HS, Kallay E, Lechner D, Gerdenitsch W, Adlercreutz H, Armbrecht HJ (2004) Phytoestrogens and vitamin D metabolism: a new concept for the prevention and therapy of colorectal, prostate, and mammary carcinomas. J Nutr 134: 1207S–1212S

    PubMed  Google Scholar 

  • Dai J, Xie Y, Wu Q et al. (2003) Molecular cloning and characterization of a novel human hydroxysteroid dehydrogenase-like 2 (HSDL2) cDNA from fetal brain. Biochem Genet 41: 165–174

    Article  PubMed  CAS  Google Scholar 

  • Deluca D, Krazeisen A, Breitling R, Prehn C, Möller G, Adamski J (2005) Inhibition of 17beta-hydroxysteroid dehydrogenases by phytoestrogens. J Ster Biochem Mol Biol 93: 285–292

    Article  CAS  Google Scholar 

  • Dinkel K, Rickert M, Möller G, Adamski J, Meinck H, Richter W (2002) Stiff-man syndrome: identification of 17beta-hydroxysteroid dehydrogenase type 4 as a novel 80-kDa antineuronal antigen. J Neuroimmunol 130: 184–193

    Article  PubMed  CAS  Google Scholar 

  • Dufort I, Rheault P, Huang XF, Soucy P, Luu-The V (1999) Characteristics of a highly labile human type 5 17beta-hydroxysteroid dehydrogenase. Endocrinology 140: 568–574

    Article  PubMed  CAS  Google Scholar 

  • Elo JP, Akinola LA, Poutanen M, Vihko P, Kyllonen AP, Lukkarinen O, Vihko R (1996) Characterization of 17beta-hydroxysteroid dehydrogenase isoenzyme expression in benign and malignant human prostate. Int J Cancer 66: 37–41

    Article  PubMed  CAS  Google Scholar 

  • English MA, Kane KF, Cruickshank N, Langman MJ, Stewart PM, Hewison M (1999) Loss of estrogen inactivation in colonic cancer. J Clin Endocrinol Metab 84: 2080–2085

    Article  PubMed  CAS  Google Scholar 

  • English MA, Hughes SV, Kane KF, Langman MJ, Stewart PM, Hewison M (2000) Oestrogen inactivation in the colon: analysis of the expression and regulation of 17beta-hydroxysteroid dehydrogenase isozymes in normal colon and colonic cancer. Br J Cancer 83: 550–558

    Article  PubMed  CAS  Google Scholar 

  • Fleshner NE, Trachtenberg J (1993) Treatment of advanced prostate cancer with the combination of finasteride plus flutamide: early results. Eur Urol 2: 106–112

    Google Scholar 

  • Francis JS (1994) Genetic skin diseases. Curr Opin Pediatr 6: 447–453

    PubMed  CAS  Google Scholar 

  • Geissler WM, Davis DL, Wu L et al. (1994) Male pseudohermaphroditism caused by mutations of testicular 17 beta-hydroxysteroid dehydrogenase 3. Nat Genet 7: 34–39

    Article  PubMed  CAS  Google Scholar 

  • Green VL, Speirs V, Landolt AM, Foy PM, Atkin SL (1999) 17Beta-hydroxysteroid dehydrogenase type 1, 2, 3, and 4 expression and enzyme activity in human anterior pituitary adenomas. J Clin Endocrinol Metab 84: 1340–1345

    Article  PubMed  CAS  Google Scholar 

  • Grunsven EG van, Berkel E van, Ijlst L et al. (1998) Peroxisomal D-hydroxyacyl-CoA dehydrogenase deficiency: Resolution of the enzyme defect and its molecular basis in bifunctional protein deficiency. Proc Natl Acad Sci USA 95: 2128–2133

    Article  PubMed  Google Scholar 

  • Gunnarsson C, Olsson BM, Stal O (2001) Abnormal expression of 17beta-hydroxysteroid dehydrogenases in breast cancer predicts late recurrence. Cancer Res 61: 8448–8451

    PubMed  CAS  Google Scholar 

  • Gurates B, Bulun SE (2003) Endometriosis: the ultimate hormonal disease. Semin Reprod Med 21: 125–134

    Article  PubMed  CAS  Google Scholar 

  • Hansis C, Jahner D, Spiess AN, Boettcher K, Ivell R (1998) The gene for the Alzheimer-associated beta-amyloid-binding protein (ERAB) is differentially expressed in the testicular Leydig cells of the azoospermic by w/w(v) mouse. Eur J Biochem 258: 53–60

    Article  PubMed  CAS  Google Scholar 

  • Harkonen P, Torn S, Kurkela R et al. (2003) Sex hormone metabolism in prostate cancer cells during transition to an androgen-independent state. J Clin Endocrinol Metab 88: 705–712

    Article  PubMed  CAS  Google Scholar 

  • He XY, Merz G, Mehta P, Schulz H, Yang SY (1999) Human brain short chain L-3-hydroxyacyl coenzyme A dehydrogenase is a single-domain multifunctional enzyme. Characterization of a novel 17beta-hydroxysteroid dehydrogenase. J Biol Chem 274: 15014–15019

    Article  PubMed  CAS  Google Scholar 

  • He XY, Wen GY, Merz G et al. (2002) Abundant type 10 17 beta-hydroxysteroid dehydrogenase in the hippocampus of mouse Alzheimer’s disease model. Brain Res Mol Brain Res 99: 46–53

    Article  PubMed  CAS  Google Scholar 

  • Henderson BE, Feigelson HS (2000) Hormonal carcinogenesis. Carcinogenesis 21: 427–433

    Article  PubMed  CAS  Google Scholar 

  • Huang Y, Tang R, Dai J et al. (2001) A novel human hydroxysteroid dehydrogenase like 1 gene (HSDL1) is highly expressed in reproductive tissues. Mol Biol Rep 28: 185–191

    Article  PubMed  CAS  Google Scholar 

  • Huggins C, Jensen EV, Cleveland AS (1954) Chemical structure of steroids in relation to promotion of growth of the vagina and uterus of the hypophysectomized rat. J Exp Med 100: 225–240

    Article  PubMed  CAS  Google Scholar 

  • Husen B, Adamski J, Bruns A et al. (2003) Characterization of 17beta-hydroxysteroid dehydrogenase type 7 in reproductive tissues of the marmoset monkey. Biol Reprod 68: 2092–2099

    Article  PubMed  CAS  Google Scholar 

  • Ivell R, Balvers M, Anand RJ, Paust HJ, McKinnell C, Sharpe R (2003) Differentiation-dependent expression of 17beta-hydroxysteroid dehydrogenase, type 10, in the rodent testis: effect of aging in Leydig cells. Endocrinology 144: 3130–3137

    Article  PubMed  CAS  Google Scholar 

  • Jakimiuk AJ, Weitsman SR, Magoffin DA (1999) 5Alpha-reductase activity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 84: 2414–2418

    Article  PubMed  CAS  Google Scholar 

  • Kiang TK, Ensom MH, Chang TK (2005) UDP-glucuronosyl-transferases and clinical drug-drug interactions. Pharmacol Ther 106: 97–132

    Article  PubMed  CAS  Google Scholar 

  • Kuhn-Velten WN (2000) Intracrinology and the local enzymatic control of hormone distribution and metabolism: dehydroepiandrosterone does not just act as a prohormone for androgens and estrogens. Eur J Clin Invest 30(Suppl 3): 34–38

    Article  PubMed  CAS  Google Scholar 

  • Labrie F, Simard J, Luu-The V, Pelletier G, Belghmi K, Belanger A (1994) Structure, regulation and role of 3 beta-hydroxysteroid dehydrogenase, 17 beta-hydroxysteroid dehydrogenase and aromatase enzymes in the formation of sex steroids in classical and peripheral intracrine tissues. Baillieres Clin Endocrinol Metab 8: 451–474

    Article  PubMed  CAS  Google Scholar 

  • Labrie F, Luu-The V, Lin SX et al. (2000) Intracrinology: role of the family of 17beta-hydroxysteroid dehydrogenases in human physiology and disease. J Mol Endocrinol 25: 1–16

    Article  PubMed  CAS  Google Scholar 

  • Lange CA (2003) Making sense of cross-talk between steroid hormone receptors and intracellular signaling pathways: Who will have the last word? Mol Endocrinol 18: 269–278

    Article  PubMed  CAS  Google Scholar 

  • Lee KA, Fuda H, Lee YC, Negishi M, Strott CA, Pedersen LC (2003) Crystal structure of human cholesterol sulfotransferase (SULT2Blb) in the presence of pregnenolone and 3-phosphoadenosine 5-phosphate. Rationale for specificity differences between prototypical SULT2A1 and the SULT2BG1 isoforms. J Biol Chem 278: 44593–44599

    Article  PubMed  CAS  Google Scholar 

  • Li X, O’Malley BW (2003) Unfolding the action of progesterone receptors. J Biol Chem 278: 39261–39264

    Article  PubMed  CAS  Google Scholar 

  • Lin B, White JT, Ferguson C et al. (2001) Prostate short-chain dehydrogenase reductase 1 (PSDR1): a new member of the short-chain steroid dehydrogenase/reductase family highly expressed in normal and neoplastic prostate epithelium. Cancer Res 61: 1611–1618

    PubMed  CAS  Google Scholar 

  • Lin HK, Jez JM, Schlegel BP, Peehl DM, Pachter JA, Penning TM (1997) Expression and characterization of recombinant type 2 3 alpha-hydroxysteroid dehydrogenase (HSD) from human prostate: demonstration of bifunctional 3 alpha/17 beta-HSD activity and cellular distribution. Mol Endocrinol 11: 1971–1984

    Article  PubMed  CAS  Google Scholar 

  • MacLeod SL, Nowell S, Plaxco J, Lang NP (2000) An allele-specific polymerase chain reaction method for the determination of the D85Y polymorphism in the human UDP-glucuronosyltransferase 2B15 gene in a case-control study of prostate cancer. Ann Surg Oncol 7: 777–782

    Article  PubMed  CAS  Google Scholar 

  • Marijanovic Z, Laubner D, Möller G, Gege C, Husen B, Adamski J, Breitling R (2003) Closing the gap: Identification of human 3-ketosteroid reductase, the last unknown enzyme of mammalian cholesterol biosynthesis. Mol Endocrinol 17: 1715–1725

    Article  PubMed  CAS  Google Scholar 

  • Martel C, Rheaume E, Takahashi M et al. (1992) Distribution of 17 beta-hydroxysteroid dehydrogenase gene expression and activity in rat and human tissues. J Steroid Biochem Mol Biol 41: 597–603

    Article  PubMed  CAS  Google Scholar 

  • Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS (2001) A transgenic model of visceral obesity and the metabolic syndrome. Science 294: 2166–2170

    Article  PubMed  CAS  Google Scholar 

  • McConnell JD, Roehrborn CG, Bautista OM et al. (2003) The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 349: 2387–2398

    Article  PubMed  CAS  Google Scholar 

  • McKenna NJ, O’Malley BW (2002) Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108: 465–474

    Article  PubMed  CAS  Google Scholar 

  • Means GD, Toy DY, Baum PR, Derry JM (2000) A transcript map of a 2-Mb BAC contig in the proximal portion of the mouse X chromosome and regional mapping of the scurfy mutation. Genomics 65: 213–223

    Article  PubMed  CAS  Google Scholar 

  • Mendonca BB, Arnhold IJ, Bloise W, Andersson S, Russell DW, Wilson JD (1999) 17Beta-hydroxysteroid dehydrogenase 3 deficiency in women. J Clin Endocrinol Metab 84: 802–804

    Article  PubMed  CAS  Google Scholar 

  • Mesia-Vela S, Kauffman FC (2003) Inhibition of rat liver sulfotransferases SULT1A1 and SULT2A1 and glucuronosyl-transferase by dietary flavonoids. Xenobiotica 33: 1211–1220

    Article  PubMed  CAS  Google Scholar 

  • Michael AE, Evagelatou M, Norgate DP et al. (1997) Isoforms of 11beta-hydroxysteroid dehydrogenase in human granulosa-lutein cells. Mol Cell Endocrinol 132: 43–52

    Article  PubMed  CAS  Google Scholar 

  • Michael AE, Thurston LM, Rae MT (2003) Glucocorticoid metabolism and reproduction: a tale of two enzymes. Reproduction 126: 425–441

    Article  PubMed  CAS  Google Scholar 

  • Mindnich R, Möller G, Adamski J (2004) The role of 17 beta-hydroxysteroid dehydrogenases. Mol Cell Endocrinol 218: 7–20

    Article  PubMed  CAS  Google Scholar 

  • Miyoshi Y, Ando A, Shiba E, Taguchi T, Tamaki Y, Noguchi S (2001) Involvement of up-regulation of 17beta-hydroxysteroid dehydrogenase type 1 in maintenance of intratumoral high estradiol levels in postmenopausal breast cancers. Int J Cancer 94: 685–689

    Article  PubMed  CAS  Google Scholar 

  • Morris DJ, Brem AS, Ge R, Jellinck PH, Sakai RR, Hardy MP (2003) The functional roles of 11 beta-HSD1: vascular tissue, testis and brain. Mol Cell Endocrinol 203: 1–12

    Article  PubMed  CAS  Google Scholar 

  • Morton NM, Holmes MC, Fievet C, Staels B, Tailleux A, Mullins JJ, Seckl JR (2001) Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice. J Biol Chem 276: 41293–41300

    Article  PubMed  CAS  Google Scholar 

  • Nandur R, Kumar K, Villablanca AC (2004) Cardiovascular actions of selective estrogen receptor modulators and phytoestrogens. Prev Cardiol 7: 73–79

    PubMed  CAS  Google Scholar 

  • Nikander E, Metsa-Heikkila M, Ylikorkala O, Tiitinen A (2004) Effects of phytoestrogens on bone turnover in postmenopausal women with a history of breast cancer. J Clin Endocrinol Metab 89: 1207–1212

    Article  PubMed  CAS  Google Scholar 

  • Nordenskjold A, Ivarsson SA (1998) Molecular characterization of 5 alpha-reductase type 2 deficiency and fertility in a Swedish family. J Clin Endocrinol Metab 83: 3236–3238

    Article  PubMed  CAS  Google Scholar 

  • Obeyesekere VR, Ferrari P, Andrews RK, Wilson RC, New MI, Funder JW, Krozowski ZS (1995) The R337C mutation generates a high Km 11 beta-hydroxysteroid dehydrogenase type II enzyme in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab 80: 3381–3383

    Article  PubMed  CAS  Google Scholar 

  • Oduwole OO, Isomaa VV, Nokelainen PA, Stenback F, Vihko PT (2002) Downregulation of estrogen-metabolizing 17 beta-hydroxysteroid dehydrogenase type 2 expression correlates inversely with Ki67 proliferation marker in colon-cancer development. Int J Cancer 97: 1–6

    Article  PubMed  CAS  Google Scholar 

  • Oppermann UC, Filling C, Jornvall H (2001) Forms and functions of human SDR enzymes. Chem Biol Interact 130–132: 699–705

    Article  PubMed  Google Scholar 

  • Oppermann U, Filling C, Hult M et al. (2003) Short-chain dehydrogenases/reductases (SDR): the 2002 update. Chem Biol Interact 143/144: 247–253

    Article  CAS  Google Scholar 

  • Payne AH, Hales DB (2004) Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev 25: 947–970

    Article  PubMed  CAS  Google Scholar 

  • Peltoketo H, Isomaa V, Poutanen M, Vihko R (1996) Expression and regulation of 17 beta-hydroxysteroid dehydrogenase type 1. J Endocrinol 150(Suppl): S21–30

    PubMed  CAS  Google Scholar 

  • Peltoketo H, Luu-The V, Simard J, Adamski J (1999 a) 17beta-hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family; nomenclature and main characteristics of the 17HSD/KSR enzymes. J Mol Endocrinol 23: 1–11

    Article  PubMed  CAS  Google Scholar 

  • Peltoketo H, Nokelainen P, Piao YS, Vihko R, Vihko P (1999b) Two 17beta-hydroxysteroid dehydrogenases (17HSDs) of estradiol biosynthesis: 17HSD type 1 and type 7. J Steroid Biochem Mol Biol 69: 431–439

    Article  PubMed  CAS  Google Scholar 

  • Penning TM (2003) Hydroxysteroid dehydrogenases and pre-receptor regulation of steroid hormone action. Hum Reprod Update 9: 193–205

    Article  PubMed  CAS  Google Scholar 

  • Penning TM, Burczynski ME, Jez JM et al. (2000) Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochem J 351: 67–77

    Article  PubMed  CAS  Google Scholar 

  • Poirier D (2003) Inhibitors of 17beta-hydroxysteroid dehydrogenases. Curr Med Chem 10: 453–477

    PubMed  CAS  Google Scholar 

  • Poirier D, Dionne P, Auger S (1998) A 6beta-(thiaheptanamide) derivative of estradiol as inhibitor of 17beta-hydroxysteroid dehydrogenase type 1. J Steroid Biochem Mol Biol 64: 83–90

    Article  PubMed  CAS  Google Scholar 

  • Rosier A, Silverstein S, Abeliovich D (1996) A (R80Q) mutation in 17 beta-hydroxysteroid dehydrogenase type 3 gene among Arabs of Israel is associated with pseudohermaphroditism in males and normal asymptomatic females. J Clin Endocrinol Metab 81: 1827–1831

    Article  Google Scholar 

  • Shapiro LJ, Yen P, Pomerantz D, Martin E, Rolewic L, Mohandas T (1989) Molecular studies of deletions at the human steroid sulfatase locus. Proc Natl Acad Sci USA 86: 8477–8481

    Article  PubMed  CAS  Google Scholar 

  • Simpson ER (2003) Sources of estrogen and their importance. J Steroid Biochem Mol Biol 86: 225–230

    Article  PubMed  CAS  Google Scholar 

  • Steckelbroeck S, Stoffel-Wagner B, Reichelt R, Schramm J, Bidlingmaier F, Siekmann L, Klingmuller D (1999) Characterization of 17beta-hydroxysteroid dehydrogenase activity in brain tissue: testosterone formation in the human temporal lobe. J Neuroendocrinol 11: 457–464

    Article  PubMed  CAS  Google Scholar 

  • Steckelbroeck S, Watzka M, Reissinger A et al. (2003) Characterisation of estrogenic 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity in the human brain. J Steroid Biochem Mol Biol 86: 79–92

    Article  PubMed  CAS  Google Scholar 

  • Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CH, Edwards CR (1987) Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age. Lancet 2: 821–824

    Article  PubMed  CAS  Google Scholar 

  • Stoffel-Wagner B (2001) Neurosteroid metabolism in the human brain. Eur J Endocrinol 145: 669–679

    Article  PubMed  CAS  Google Scholar 

  • Stoffel-Wagner B, Watzka M, Steckelbroeck S, Schramm J, Bidlingmaier JF, Klingmuller D (1999) Expression of 17beta-hydroxysteroid dehydrogenase types 1, 2, 3 and 4 in the human temporal lobe. J Endocrinol 160: 119–126

    Article  PubMed  CAS  Google Scholar 

  • Stott WT, Kan HL, McFadden LG, Sparrow BR, Gollapudi BB (2004) Effect of strain and diet upon constitutive and chemically induced activities of several xenobiotic-metabolizing enzymes in rats. Regul Toxicol Pharmacol 39: 325–333

    Article  PubMed  CAS  Google Scholar 

  • Suzuki T, Moriya T, Ishida T, Kimura M, Ohuchi N, Sasano H (2002) In situ production of estrogens in human breast carcinoma. Breast Cancer 9: 296–302

    Article  PubMed  Google Scholar 

  • Thomas JL, Myers RP, Strickler RC (1989) Human placental 3 beta-hydroxy-5-ene-steroid dehydrogenase and steroid delta5-delta4-ene-isomerase: purification from mitochondria and kinetic profiles, biophysical characterization of the purified mitochondrial and microsomal enzymes. J Steroid Biochem 33: 209–217

    Article  PubMed  CAS  Google Scholar 

  • Thomas JL, Mason JI, Blanco G, Veisaga ML (2001) The engineered, cytosolic form of human type I 3beta-hydroxy-steroid dehydrogenase/isomerase: purification, characterization and crystallization. J Mol Endocrinol 27: 77–83

    Article  PubMed  CAS  Google Scholar 

  • Tomlinson JW, Walker EA, Bujalska IJ et al. (2004) 11Beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev 25: 831–866

    Article  PubMed  CAS  Google Scholar 

  • Traupe H, Muller-Migl CR, Kolde G, Happle R, Kovary PM, Hameister H, Ropers HH (1984) Ichthyosis vulgaris with hypogenitalism and hypogonadism: evidence for different genotypes by lipoprotein electrophoresis and steroid sulfatase testing. Clin Genet 25: 42–51

    Article  PubMed  CAS  Google Scholar 

  • Tremblay MR, Luu-The V, Leblanc G, Noel P, Breton E, Labrie F, Poirier D (1999) Spironolactone-related inhibitors of type II 17beta-hydroxysteroid dehydrogenase: chemical synthesis, receptor binding affinities, and proliferative/antiproliferative activities. Bioorg Med Chem 7: 1013–1023

    Article  PubMed  CAS  Google Scholar 

  • Torn S, Nokelainen P, Kurkela R et al. (2003) Production, purification, and functional analysis of recombinant human and mouse 17beta-hydroxysteroid dehydrogenase type 7. Biochem Biophys Res Commun 305: 37–45

    Article  PubMed  CAS  Google Scholar 

  • Vihko P, Harkonen P, Oduwole O et al. (2002) 17Beta-hydroxysteroid dehydrogenases and cancers. J Steroid Biochem Mol Biol 83: 119–122

    Article  PubMed  CAS  Google Scholar 

  • Weihua Z, Lathe R, Warner M, Gustafsson JA (2002) An endocrine pathway in the prostate, ERbeta, AR, 5alpha-androstane-3beta,17beta-diol, and CYP7B1, regulates prostate growth. Proc Natl Acad Sci USA 99: 13589–13594

    Article  PubMed  CAS  Google Scholar 

  • Weill-Engerer S, David JP, Sazdovitch V et al. (2003) In vitro metabolism of dehydroepiandrosterone (DHEA) to 7alpha-hydroxy-DHEA and Delta5-androstene-3beta, 17beta-diol in specific regions of the aging brain from Alzheimer’s and non-demented patients. Brain Res 969: 117–125

    Article  PubMed  CAS  Google Scholar 

  • Wiebe JP, Lewis MJ (2003) Activity and expression of progesterone metabolizing 5alpha-reductase, 20alpha-hydroxysteroid oxidoreductase and 3alpha(beta)-hydroxysteroid oxidoreductases in tumorigenic (MCF-7, MDA-MB-231, T-47D) and nontumorigenic (MCF-10 A) human breast cancer cells. BMC Cancer 3: 9

    Article  PubMed  Google Scholar 

  • Wu L, Einstein M, Geissler WM, Chan HK, Elliston KO, Andersson S (1993) Expression cloning and characterization of human 17 beta-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20 alpha-hydroxysteroid dehydrogenase activity. Journal of Biological Chemistry 268: 12964–12969

    PubMed  CAS  Google Scholar 

  • Wuttke W, Jarry H, Becker T, Schultens A, Christoffel V, Gorkow C, Seidlova-Wuttke D (2003) Phytoestrogens: endocrine disrupters or replacement for hormone replacement therapy? Maturitas 44Suppl 1: S9–20

    Article  PubMed  CAS  Google Scholar 

  • Yan SD, Fu J, Soto C et al. (1997) An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer’s disease. Nature 389: 689–695

    Article  PubMed  CAS  Google Scholar 

  • Yoshinari K, Petrotchenko EV, Pedersen LC, Negishi M (2001) Crystal structure-based studies of cytosolic sulfotransferase. J Biochem Mol Toxicol 15: 67–75

    Article  PubMed  CAS  Google Scholar 

  • Zhang Y, Dufort I, Rheault P, Luu-The V (2000) Characterization of a human 20alpha-hydroxysteroid dehydrogenase. J Mol Endocrinol 25: 221–228

    Article  PubMed  Google Scholar 

  • Zhu DW, Lee X, Breton R, Ghosh D, Pangborn W, Daux WL, Lin SX (1993) Crystallization and preliminary X-ray diffraction analysis of the complex of human placental 17 beta-hydroxysteroid dehydrogenase with NADP+. J Mol Biol 234: 242–244

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. GSF-Forschungszentrum für Umwelt und Gesundheit, Ingolstädter Landstraße 1, 85764, Neuherberg

    Prof. Dr. Jerzy Adamski

Authors
  1. Prof. Dr. Jerzy Adamski
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Charité — Universitätsmedizin Berlin, Schumannstr. 20/21, 10117, Berlin

    Detlev Ganten (Der Vorstandsvorsitzende (CEO) (Der Vorstandsvorsitzende (CEO)

  2. Max-Delbrück-Centrum für Molekulare Medizin (MDC), Robert-Rössle-Straße 10, 13122, Berlin-Buch

    Klaus Ruckpaul

  3. Charité Campus Mitte Institut für Experimentelle Endokrinologie, Charité — Universitätsmedizin Berlin, Schumannstraße 20/21, 10117, Berlin

    Josef Köhrle

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Adamski, J. (2006). Lokale Aktivierung und Inaktivierung der Steroidhormone, insbesondere der Sexualhormone. In: Ganten, D., Ruckpaul, K., Köhrle, J. (eds) Molekularmedizinische Grundlagen von para- und autokrinen Regulationsstörungen. Molekulare Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-28782-5_23

Download citation

Publish with us

Policies and ethics

Search

Navigation